drugset / Trial / NCT06995820
A Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of AZD1613 in Healthy Participants.
RandomizedSequentialSingle-blindTreatment
Summary
The purpose of the study is to assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and immunogenicity of AZD1613 in healthy participants, including Japanese and Chinese descent.
Timeline
- Start
- 2025-06-06
- Primary completion
- 2026-09-23
- Completion
- 2026-09-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD1613 | Unknown | — | Subcutaneous |
Indications
No indication recorded.